Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a special foam dressing speed up wound healing?

NCT ID NCT07782008

Symptom relief Sponsor: Molnlycke Health Care AB Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This trial is testing a soft silicone foam dressing called Mepilex Up on adults with leg or foot ulcers and skin tears. The goal is to see if the dressing helps wounds progress toward healing and is safe to use. About 70 participants will use the dressing for up to 6 weeks, and doctors will check how their wounds change over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mepilex Up, a soft silicone foam dressing for wound management
What this could lead to
If successful, this dressing could offer a reliable, safe option to help heal leg and foot ulcers and skin tears, potentially improving quality of life for many patients.
What could go wrong
This is a small, non-comparative study, so results may not apply broadly. Some people may have allergic reactions or the dressing may not work for all wound types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Signed informed consent. 2. Adults aged ≥18 years 3. Exudate levels moderate to high 4. Wound sizes: 1. Leg ulcers: between 3 cm² and 30 cm² 2. Foot ulcers: ≥0,75 cm² 3. Skin tears: between 3 cm² and 30 cm² 5. Pressure ulcers: Foot ulcer caused by pressure Exclusion Criteria: 1. Circumferential ulcer 2. Known allergy/hypersensitivity to the materials of the dressings or products 3. Use of wound fillers 4. Infected ulcer/wound, defined as any wound condition requiring the prescription or continuation of systemic antibiotics (orally or parental) at enrolment 5. Participating in ongoing clinical investigations, or during the past 30 days, which may impact the outcome of this investigation based on the judgement of the investigator 6. Woman of childbearing potential, who is pregnant or breastfeeding or plans on becoming pregnant during the investigation period 7. Not willing or able to comply to clinical investigation procedures, or not suitable for participation according to the investigator (e.g., alcohol or substance abuse)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot ulcer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

decubitus ulcer Diabetic Foot Foot Ulcer Leg Ulcer ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic foot ulcer Foot ulcer Leg ulcer Pressure ulcer (PU) Skin tears

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Forsåker Vårdcentral

    Mölndal, Västra Götaland County, 43133, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.